- Home
- HKIT vs CVM Comparison
HKIT vs CVM Comparison
Compare HKIT & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HKIT | CVM |
|---|---|---|
| Founded | 1996 | 1983 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.2M | 53.1M |
| IPO Year | 2023 | 1987 |
Fundamental Metrics
Financial Performance| Metric | HKIT | CVM |
|---|---|---|
| Price | $1.78 | $6.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 169.2K | 70.7K |
| Earning Date | 04-08-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,812,901.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $1.98 |
| 52 Week High | $4.18 | $20.41 |
Technical Indicators
Market Signals| Indicator | HKIT | CVM |
|---|---|---|
| Relative Strength Index (RSI) | 42.61 | 55.04 |
| Support Level | $1.40 | $5.01 |
| Resistance Level | $2.31 | $6.37 |
| Average True Range (ATR) | 0.23 | 0.51 |
| MACD | -0.03 | 0.20 |
| Stochastic Oscillator | 26.81 | 93.22 |
Price Performance
Historical ComparisonAbout HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.